未登录

J

John Rhodes

Harvard University

H指数:23

被引数:2,434

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization (vol 10, 1562, 2019)

NATURE COMMUNICATIONS

IF15.7

2019-05-077

OAAI

N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization

NATURE COMMUNICATIONS

IF15.7

2019-04-0551

OAAI

Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2014-11-17149

OAAI

Science and technology consortia in US biomedical research: A paradigm shift in response to unsustainable academic growth

IF2.7

2014-11-127

PREAI

Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCα in a Rac1 activation pathway

JOURNAL OF CELL BIOLOGY

IF6.4

2009-07-0670

OAAI

CROHNS-DISEASE IN JEWISH PEOPLE - AN EPIDEMIOLOGIC-STUDY IN SOUTHEAST WALES

IF3.6

2009-01-2933

PREAI

A randomized trial of nicotine enemas for active ulcerative colitis

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2005-11-0153

PREAI

Role of smoking in inflammatory bowel disease: implications for therapy

吸烟在炎症性肠病中的作用: 对治疗的影响

POSTGRADUATE MEDICAL JOURNAL

IF2.7

2000-05-0158

OAAI

NICOTINE TREATMENT IN ULCERATIVE-COLITIS - CURRENT STATUS

IF14.4

1995-02-018

PREAI

EFFECT OF INFORMATION BOOKLET ON PATIENTS ANXIETY LEVELS AND CONSULTATION RATES IN CROHNS-DISEASE

IF3.2

1986-05-0138

PREAI

INFORMATION ASSESSMENT BY PATIENTS OF A BOOKLET ON CROHNS-DISEASE

IF3.2

1985-07-0116

PREAI